Juergen Rockstroh - Concepedia

Author

Juergen Rockstroh

Also Known As

Andreas Plettenberg, Bam, Rujuta A., Gundolf Schüttfort, Hartwig H F Klinker, Hartwig Klinker, John Gill, Juergen K Rockstroh, Juergen K. Rockstroh, Juergen Kurt Rockstroh, Juergen Rockstroh

Publications

5.4K

Citations

H-Index

Concepts

All Affiliations

University of Bonn University Hospital Bonn University College London Center for HIV and Hepatogastroenterology The Royal Free Hospital

About

Juergen Rockstroh is an author at University of Bonn specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	890
2	Public Health	3	3	242
3	Epidemiology	3	3	170
4	Genetic Medicine	1	1	55
5	Global Health	1	1	164

Juergen Rockstroh

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022 John Thornhill, Sapha Barkati, Sharon Walmsley, New England Journal of Medicine	2022	2.1K
HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8+ T Cell Response against HIV-1 Marcus Altfeld, Elizabeth T. Kalife, Qi Ying, PLoS Medicine	2006	300
Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel Vincent Soriano, Massimo Puoti, Maurizio Bonacini, AIDS Hiv-hbv International PanelHepatologyHealth PolicyFollowing ErrorViral Hepatitis	2005	164
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial Jean‐Michel Molina, Kathleen Squires, Paul E. Sax, The Lancet HIV Treatment And PreventionAntiviral Drug DevelopmentClinical TrialsAntiviral TherapyNon-inferiority Trial	2018	140
Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus‐associated Hodgkin's disease Christian Hoffmann, Kai Uwe Chow, Eva Wolf, British Journal of Haematology ImmunologyAntiviral DrugImmunotherapyHuman ImmunodeficiencyCox Model	2004	92
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial Jean‐Michel Molina, Kathleen Squires, Paul E. Sax, The Lancet HIV Treatment And PreventionAntiretroviral-naive AdultsClinical TrialsAntiviral Drug DevelopmentAntiviral Therapy	2019	92
Immunological and Virological Impact of Highly Active Antiretroviral Therapy Initiated during Acute HIV‐1 Infection Hendrik Streeck, Heiko Jessen, Galit Alter, The Journal of Infectious Diseases	2006	89
Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection Guenther Schmutz, Mark Nelson, Thomas A. Lutz, AIDS	2006	81
Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era Patrick Ingiliz, Malte H. Wehmeyer, Christoph Boesecke, Clinical Infectious Diseases	2019	69
Gilbert’s syndrome and hyperbilirubinemia in protease inhibitor therapy – An extended haplotype of genetic variants increases risk in indinavir treatment Tim O. Lankisch, Georg M. N. Behrens, Ursula Ehmer, Journal of Hepatology Autoimmune DiseaseGenetic DisorderImmunodeficienciesInherited Metabolic DiseaseImmunology	2009	55

Page 1